인공 심장판막 기능부전 환자에서의 심장판막 재치환술

Reoperation for Dysfunction of Cardiac Valve Prosthesis

  • 윤정섭 (가톨릭대학교 의과대학 흉부외과학교실) ;
  • 김치경 (가톨릭대학교 의과대학 흉부외과학교실) ;
  • 조규도 (가톨릭대학교 의과대학 흉부외과학교실) ;
  • 이성호 (가톨릭대학교 의과대학 흉부외과학교실) ;
  • 곽문섭 (가톨릭대학교 의과대학 흉부외과학교실) ;
  • 김세화 (가톨릭대학교 의과대학 흉부외과학교실)
  • 발행 : 1998.03.01

초록

1989년 1월부터 1995년 12월까지 27예에서 심장판막 재치환술을 시행하였다. 남자 11예, 여자 16예로 평균연령은 43.51+12.2세 이었다. 기왕의 판막치환은 12예가 조직판막이었고 15예가 기계판막이었다. 인공심장판막이 재치환수술까지 체내에 있었던 기간은 조직판막이 104.91+34.9개월, 기계판막이 55.21+43.7개월이었다. 재치환된 판막은 승모판막 17예, 대동맥판 8예, 삼첨판 1예 그리고 1예는 Cabrol수술을 다시 시행한 경우이다. 재치환의 원인은 조직판막에서 판막의 구조적 결함이 전 예에서 관찰되었으며 그 외에 판막주위누출 2예와 심내막염 1예가 이었다. 기계판막에서는 판막주위조직의 침윤이 8예, 판막주위누출 4예, 판막혈전 3예가 있었으며 판막주위누출 4예중 1예는 Cabrol수술후 인조혈관의 파열이 동반되었다. 술후 합병증(25.9%)으론 창상감염 3예, 미추부 피부괴저 1예, 저심박출증 1예, 심방조동 1예 그리고 방실차단 1예 이었다. 술후 조기사망은 1명이 저심박출증으로 사망하였고 평균 49.5개월간의 추적관찰중 1명이 확장성 심근증으로 수술 3년후에 사망하였다.

From January 1988 to December 1995, 27 patients, 11 men and 16 women, underwent surgical intervention at our institution for prosthetic valve dysfunctions. The mean age was 43.5$\pm$12.2 years. Seventeen(63.0%) patients had the mitral valve replacement, 8(29.6%) the aortic valve, 1(3.7%) the aortic composite graft, and 1(3.7%) the tricuspid valve. Mean follow-up period was 49.5$\pm$30.9 months. In 12 bioprostheses, mean interval between the previous valve replacement and the reoperation was 104.9$\pm$34.9 months. The causes of redo surgery were structural deterioration of the prosthetic valve (12/12, 100%), paravalvular leak (2/12, 16.7%), and prosthetic valve endocarditis(1/12, 8.3%). In 15 mechanical prostheses, the mean interval was 55.2$\pm$43.7 months. The causes of redo surgery were pannus formation (8/15, 53.3%), paravalvular leak(4/15, 26.7%), and valve thrombosis(3/15, 20.0%). Posto- perative complications occurred in 7 patients (25.9%). There was no intraoperative death. But one patient, who received mechanical aortic valve replacement died on the 3rd postoperative day due to low cardiac output and multiorgan failure.

키워드

참고문헌

  1. Ann Thorac Surg v.47 Intrinsic failure of Hancock mitral bioprosthesis. 10-15 year experience Foster AH;Greenberg GJ;Underhill DJ;McIntosh CL;Clark RE
  2. J Thorac Cardiovasc Surg v.90 Results of reoperation for primary tissue failure of porcine bioprostheses Bortolotti U;Milano A;Mazzucco A;Valfre C(et al)
  3. 대흉외지 v.20 Hancock판막의 임상적 평가 김종환
  4. Ann Thorac Surg v.46 Guidelines for reporting morbidity and mortality after cardiac valve operations Edmunds LH Jr;Clark RE;Clark RE;Cohn LH;Miller DC;Wiesel RD
  5. 대흉외지 v.28 인공심장판막의 재치환술 김관민;임청;김기봉(등)
  6. J Thorac Cardiovasc Surg v.92 6-year to 10-year follow-up of patients with the Hancock cardiac bioprosthesis: incidence of primary tissue valve failure Gallo I;Nistal F;Artinanao E
  7. J Thorac Cardiovac Surg v.85 Late results after mitral valve replacement with the Bjork-Shiley and porcin prosthesis Marshall WG Jr;Kouchoukos NT;Karp RB;Wiliams JB
  8. Ann Thorac Surg v.36 Failure of Hancock xengraft valve: importance of valve position(4- to 9-year follow up) Bolooki H;Mallon S;Kaiser GA(et al)
  9. J Thorac Cardiovasc Surg v.78 Long-term evaluation of the porcine xenograft bioprosthesis Oyer PE;Stinson EB;Reitz BA(et al)
  10. Ann Thorac Surg v.63 Obstruction of mechanical mitral prosthesis: Analysis of pathologic findings Vitale N;Renzulli A;Agozzino L(et al)
  11. Ann Thorac Surg v.57 Prosthetic valve obstruction: thrombolysis versus operation Vitale N;Renzulli A;Cerasoulo F(et al)
  12. J Thorac Cardiovasc Surg v.92 St. Jude Medical valve replacement Keasely RH;Antunes MJ;Colsen PR
  13. Am J Cardiol v.59 Isolated replacement of a prosthesis or a bioprosthesis in the mitral valve position Antunes MJ;Magalhaes MP
  14. J Thorac Cardiovasc Surg v.94 Comparative analysis of mechanical and bioprosthetic valves after aortic valve replacement Borkon AM;Soule LM;Baughman KL(et al)
  15. 대흉외지 v.25 승모판 수술환자에 있어서 심장세동과 색전증에 영향을 주는 요소 조광조;김종원;정황규
  16. Ann Intern Med v.86 Prosthetic valve endocarditis Wilson WR;Jaumin RM;Danielson GK(et al)
  17. J Thorac Cardiovasc Surg v.77 Prosthetic valve reoperations-Factor influencing early and late survival Syracuse DC;Bowman FO;Malm JR
  18. J Thorac Cardiovasc Surg v.88 Early and late prognosis after reoper ations for prosthetic valve replacement Bosch X;Pomar JL;Pelletier CL(et al)
  19. J Thorac Cardiovasc Surg v.82 Hospital mortality of re-replacement of the aortic valve Wideman FE;Blackstone EH;Kirklin JW(et al)
  20. Circulation v.72 Death and other time-related events after valve replacement Blackstone EH;Kirklin JW